Citius Pharmaceuticals Inc. Common reported a net loss of $39.7M in fiscal year 2025. This represents a decrease of 0.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Citius Pharmaceuticals Inc. Common has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CTXR Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$39.7M-0.8% | -$39.4M-21.2% | -$32.5M+3.3% | -$33.6M-45.9% | -$23.1M-31.4% | -$17.5M-12.8% | -$15.6M-24.1% | -$12.5M-20.7% | -$10.4M-25.2% | -$8.3M-185.8% | -$2.9M-293.4% | -$738K+42.7% | -$1.3M | N/A | N/A |
CTXR Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Citius Pharmaceuticals Inc. Common financials
Frequently Asked Questions
What was Citius Pharmaceuticals Inc. Common's net income in fiscal year 2025?
Citius Pharmaceuticals Inc. Common reported a net loss of $39.7M in fiscal year 2025.
How fast is Citius Pharmaceuticals Inc. Common's net income growing?
Citius Pharmaceuticals Inc. Common (CTXR) net income fell by 0.8% year over year, from -$39.4M to -$39.7M in fiscal year 2025.
What was Citius Pharmaceuticals Inc. Common's net income in the most recent quarter?
Citius Pharmaceuticals Inc. Common (CTXR) reported -$11.9M in net income in Q3 2026. This represents a decrease of 29.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Citius Pharmaceuticals Inc. Common (CTXR) reported on that line in every period on record.